TP53 and colonic neoplasm: Targeting SIRT1, sirtinol-caused hyperacetylation of p53, Ku70, and FOXO3a, as well as phosphorylation of MAPK, leads to significant cytotoxic effect on breast and colon cancer cells21, 22.